Brind.

Jeremy Levin was appointed Chairman and CEO of Ovid Therapeutics.

1 report, 1 independent Updated Aug 13
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Jeremy Levin was appointed Chairman and CEO of Ovid Therapeutics.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireOvid Therapeutics Reports Business Updates and Second Quarter 2025 Financial Results Topline results from the OV329 Phase 1 safety, tolerability and biomarker study remain on track for a readout in Q